Abingworth

edit

Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.

Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.

Milestones

edit

• 
  Abingworth invested in PrimeraDx. (10/30/09)
  Posted 10/30/09 at 5:51pm
• 
  Abingworth invested in Zogenix. (9/23/09)
  Posted 9/24/09 at 2:04am
• 
  Abingworth invested in Intellikine. (7/22/09)
  Posted 7/28/09 at 1:25pm
• 
  Abingworth invested in Chroma Therapeutics. (6/23/09)
  Posted 7/7/09 at 12:28pm
• 
  Abingworth invested in Clovis Oncology. (5/26/09)
  Posted 6/17/09 at 11:15am
• 
  Abingworth invested in Synosia Therapeutics. (1/09)
  Posted 5/20/09 at 2:28pm
• 
  Abingworth invested in Synosia Therapeutics. (1/5/07)
  Posted 9/16/09 at 2:50am
• 
  Abingworth invested in Broncus Technologies, Inc. .
  Posted 1/23/09 at 8:49pm

Investments

Videos

Sources

1. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
2. Zogenix rounds up $51M for product roll-out (fiercebiotech.com) [edit]
3. Intellikine, Inc.: Series B $51M (onbiovc.com) [edit]
4. Capital Report Index [edit]
5. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
6. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
7. Neurological co. Synosis raises $32.5M (deals.venturebeat.com) [edit]
8. Broncus Technologies lines up venture debt financing for emphysema treatment (venturebeat.com) [edit]